Summary
This report deals with the cleavage reaction of calf thymus (CT) topoisomerase II with oligonucleotides containing one main cleavage site and adjacent binding sites for minor groove binders. The sequences of the oligonucleotides were derived from a pBR 322 sequence, which contains one main topoisomerase II cleavage site. The cleavage reaction was performed under increasing concentrations of minor groove binders and it showed characteristic inhibition dependences of topoisomerase II to the binding sites and to the binding length of the minor groove binders. The extension of the minor groove binder length on DNA from 4 to 10 base pairs (bp) by netropsin and bis-netropsin, respectively, causes a strong increase of the topoisomerase II cleavage inhibition. The same is observed by the introduction of a second minor groove binder sequence symmetrically positioned around the topoisomerase II main cleavage site. The combination of two different minor groove binders can lead to an increased topoisomerase II inhibition but also to a prevention of total inhibition as shown with chromomycin A3 and distamycin A at concentrations of 0.1 and 0.25 μM, respectively.
Similar content being viewed by others
References
Geliert M: DNA topoisomerases. Annu Rev Biochem 50:879–910, 1981
Wang JC: DNA topoisomerases. Annu Rev Biochem 54:665–697, 1985
Wang JC: DNA topoisomerases: why so many? J Biol Chem 266:6659–6662, 1991
Roca J, Wang JC: DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism. Cell 77:609–161, 1994
Roca J: The mechanisms of DNA topoisomerases. TIBS 20:156–160, 1995
Thomson B, Bednixen C, Lund K, Andersen AH, Sørensen BS, Westergaard O: Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting. J Mol Biol 215:237–244, 1990
Spitzner JR, Chung JK, Muller MT: Eucaryotic topoisomerase II preferentially cleaves alternating purinepyrimidine repeats. Nucl Acids Res 18:1–11, 1989
Lund K, Andersen AH, Christiansen K, Svejstrup JW, Westergaard O: Minimal DNA requirement for topoisomerase II-mediated cleavage in vitro. J Biol Chem 265: 13856–13863, 1990
Sander M, Hsieh T-S: Double strand DNA cleavage by type II DNA topoisomerase from drosophila melanogaster. J Biol Chem 258:8421–8428, 1983
Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL: Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem 258:15365–15370, 1983
Nelson EM, Tewey KM, Liu LF: Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-aniside. Proc Nat Acad Sci USA 81: 1361–1365, 1984
Maxwell A, Geliert M: Mechanistic aspects of DNA topoisomerases. In: Afinsen CB, Edsall JT, Richards FM (eds) Advan Protein Chem 38. Academic Press, inc., 1986, pp. 69–107
Sørensen BS, Sinding J, Andersen AH, Alsner J, Jensen PB, Westergaard O: Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: uncoupling the DNA binding, cleavage and religation events. J Biol Chem 228:778–786, 1992
Liu LF: DNA topoisomerase poisons as antitumor drugs. Ann Rev Biochem 58:351–375, 1989
D'Arpa P, Liu LF: Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 989:163–177, 1989
Waring MJ: DNA modification and cancer. Ann Rev Biochem 50:159–192, 1981
Zimmer C: Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids. Prog Nucleic Acid Res Mol Biol 15:285–318, 1975
Gilbert DE, Feigon J: Structural analysis of drug-DNA interactions. Curr Opin Struct Biol 1:439–445, 1991
Zimmer C, Wähnert U: Nonintercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Progr Biophys molec Biol 47:31–112, 1986
Neidle S, Pearl LH, Skelly JV: DNA structure and perturbation by drug binding. Biochem J 243:1–13, 1987
Simon H, Wittig B, Zimmer C: Effect of netropsin, distamycin A and chromomycin A3 on the binding and cleavage reaction of DNA gyrase. FEES Lett 353:79–83, 1994
Beerman TA, Woynarowski JM, Sigmund RD, Gawron LS, Rao KE, Lown JW: Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes. Biochim Biophys Acta 1090:52–60, 1991
Rao KE, Krowicki K, Balzarini J, De Clercq E, Newman RA, Lown JW: Novel linked antiviral and antitumor agents related to netropsin-2: synthesis and biological evaluation. Actual Chim Thér 18:21–42, 1991
Chen AY, Yu C, Gatto Liu LF: DNA minor groove binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc Nat Acad Sci USA 90:8131–8135, 1993
Lown JW: DNA recognition by lexitropsins, minor groove binding agents. J Mol Recogn 7:79–88, 1994
Gao X, Patel DJ: Solution structure of the chromomycin-DNA complex. Biochemistry 28:751–762, 1989
Banville DL, Keniry MA, Kam M, Shafer RH: NMR studies of the interaction of chromomycin A3 with small DNA duplexes: binding to GC-containing sequences. Biochemistry 29:6521–6534, 1990
Itzhaki L, Weinberger S, Livnah N, Berman E: A unique binding cavity for divalent cations in the DNA-metalchromomycin A3 complex. Biopolymers 29:481–489, 1990
Gao X, Mirau P, Patel DJ: Structure refinement of the chromomycin dimer-DNA oligomer complex in solution. J Mol Biol 223:259–279, 1992
Stankus A, Goodisman J, Dabrowiak JC: Quantitative footprinting analysis of the chromomycin A3-DNA interaction. Biochemistry 31:9310–9318, 1992
Silva DJ, Kahne D: Chromomycin A3 as a blueprint for designed metal complexes. J Am Chem Soc 116:2641–2642, 1994
Woynarowski JM, McHugh M, Sigmund RD, Beerman TA: Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, hoechst 33258, and 4′,6-diamidine-2-phenylindole. Mol Pharmacol 35:177–182, 1989
Strausfeld U, Richter A: Simultaneous purification of DNA topoisomerase I and II from eukaryotic cells. Prep Biochem 19:37–48, 1989
Andersen AH, Sørensen BS, Christiansen K, Svejstrup JQ, Lund K, Westergaard O: Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate. J Biol Chem 266:9203–9210, 1991
Hesse G, Geller K: Untersuchungen zur Phosphorbestimmung (Nukleotidphosphor) nach Hurst mit einem SnCl2/Hydrazinsulfatreagenz. Mikrochim Acta (Wien): 526–533, 1968
Kissinger KL, Dabrowiak JC, Lown JW: Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis netropsin analogues deduced from footprinting analysis. Chem Res Toxicol 3:162–168, 1990
Keniry MA, Banville DL, Simmonds PM, Shafer R: Nuclear magnetic resonance comparison of the binding sites of mithramycin and chromomycin on the self-complementary oligonucleotide d(ACCCGGGT)2: evidence that the saccharide chains have a role in sequence specificity. J Mol Biol 231:753–767, 1993
Lin C, Chen FM: Oligonucleotide studies of sequence-specific binding of chromomycin A3 to DNA. Biochemistry 33:1419–1424, 1994
Portugal J, Waring MJ: Assignment of DNA binding sites for 4′,6-diamidine-2-phenylindole and bisbenzimide (Hoechst 33258): a comparative footprinting study. Biochim Biophys Acta 949:158–168, 1988
Wilson WD, Tanious FA, Barton HJ, Jones RL, Fox K, Wydra RL, Strekowski L: DNA-sequence dependent binding modes of 4′,6-diamidino-2-phenylindole (DAPI). Biochemistry 29:8452–8461, 1990
Mortensen UH, Stevnsner T, Krogh S, Olesen K, Westergaard O, Bonven BJ: Distamyicn inhibition of topoisomerase I-DNA interaction: a mechanistic analysis. Nucl Acids Res 18:1983–1989, 1990
Pelton JG, Wemmer DE: Structural characterization of a 2∶1 distamycin A.d(CGCAAATTGGC) complex by two-dimensional NMR. Proc Nat Acad Sci USA 86:5723–5727, 1989
Chen X, Ramakrishnan B, Rao ST, Sundaralingam M: Binding of two distamycin A molecules in the minor groove of an alternating B-DNA duplex. Nat Struct biol 1:169–175, 1994
Geierstanger BH, Mrksich M, Dervan PB, Wemmer DE: Design of a G.C-specific DNA minor groove-binding peptide. Science 266:646–650, 1994
Kopka ML, Yoon C, Goodsell D, Pjura P, Dickerson RE: The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc Nat Acad Sci USA 82:1376–1380, 1985
Coll M, Frederick CA, Wang AH-J, Rich A: A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin. Proc Nat Acad Sci USA 84: 8385–8389, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bell, A., Kittler, L., Löber, G. et al. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides. Invest New Drugs 13, 271–284 (1995). https://doi.org/10.1007/BF00873133
Issue Date:
DOI: https://doi.org/10.1007/BF00873133